Test Report

TEST REPORT
Name : Mr. Ashok Bhosle Reg. No : 403200070

Age/Sex : 69 Years / Male Passport No : Reg. Date : 13-Mar-2024 08:27 AM
Ref. By : Dr. N.S.INGLE Collected On : 13-Mar-2024 08:27 AM
Client Name : Report Date : 13-Mar-2024 01:55 PM
Parameter Result Unit Biological Ref. Interval

FASTING PLASMA GLUCOSE
Fasting Blood Sugar (FBS) 70.09 mg/dL Normal <= 99

Prediabetes=100-125
Diabetes>= 126
Urine Glucose -F Not voided
Urine Acetone -F Not voided
Sample Type : Flouride F
Criteria for the diagnosis of diabetes
1. HbA1c >/= 6.5 *

Or
403200070-Mr. Ashok Bhosle-69 Years-Male
2. Fasting plasma glucose >126 gm/dL. Fasting is defined as no caloric intake at least for 8 hrs.
Or
3. Two hour plasma glucose >/= 200mg/dL during an oral glucose tolerence test by using a glucose load containing
equivalent of 75 gm anhydrous glucose dissolved in water.
Or
4. In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose >/= 200
mg/dL.
*In the absence of unequivocal hyperglycemia, criteria 1-3 should be confirmed by repeat testing.
American diabetes association. Standards of medical care in diabetes 2011. Diabetes care 2011;34;S11.
Report status : Final

Dr. Namdev Tilokani Validated by : DRTRILOKANI
MD(Path) Approved by : DRTILOKANI
G-4265
Page 1 of 6
TEST REPORT
Ref. By : Dr. N.S.INGLE Collected On : 13-Mar-2024 02:13 PM

PLASMA GLUCOSE / BLOOD SUGAR -URINE SUGAR ESTIMATION
( by automated analyser of diatron p 500 )
Post Prandial Blood Sugar (PPBS) 163.14 mg/dL Normal <=139

Prediabetes = 140-199
Diabetes >=200
Urine Glucose- PP Not voided
Urine Acetone- PP Not voided
Sample Type : Flouride PP

Dr. Namdev Tilokani Validated by : AJAY
G-4265
Page 2 of 6
TEST REPORT

Estimated GLOMERULAR FILTRATION RATE ( eGFR )
Creatinine 1.17 mg/dL 0.4 - 1.4

Sarcosine Oxidase Method
EGFR 61.81
MDRD GFR Equation
Sample Type : Serum
The MDRD eGFR is NOT a sensitive test for renal failure and can not be used to detect mild renal impairment
( eGFR 60 - 90 ml / min / 1.73 m2 )
This is a recommendation of peak renal and pathology bodies in Australia ( Chronic Kidney disease and auto
matic reporting of glomerular filtration rate - CKD )
The results are expressed relative to standard body surface area of 1.73 m2
The equation is only valid in person 18 yrs of age or older

The use of eGFR in patient on dialysis is inappropriate and will give misleading results
The formula has not been validated for drug dosing , in such case alternate eGFR equation by
Cockcroft and Gault should be used.
Results may deviate from true values in patient with exceptional dietary intake ( vegetarian diet , high
protein intake , creatine supplements ) and extreme body composition ( lean , obese , paraplegic )and
severe liver disease.
Results > 60 ml / min / 1.73 m2 do not necessarily indicates normal renal functions.
The most sensitive routine test for small reduction in GFR is a comparision of S. Creatinine with previous result
An increase of 15 % or more in S. Creatnine indicates significant fall in eGFR

Dr. Namdev Tilokani Validated by : DRTRILOKANI
G-4265
Page 3 of 6
TEST REPORT
HbA1c (by automated analyser NANO H5)
Hb A1C 7.6 mg/dL <6 : Non-diabetic level /

Near normal glycemia
6 - 6.9 : Good glycemic
control
7 - 8 : Fair glycemic
control
>8 : Poor glycemic
control
Mean Blood Glucose 171.42 mg/dL

Calculated
COMMENT Fair glycemic control mg/dL

Calculated
Sample Type : EDTA Whole Blood

MD(Path) Approved by : DRTRILOKANI
G-4265
Page 4 of 6
TEST REPORT
Interpretation ( % Glyco Hb ):
>8 Poor glycemic control
7-8 Fair glycemic control
6-6.9 Good glycemic control
<6 Non-diabetic level/Near normal glycemia
* High risk of developing long term complication such as retinopathy, nephropathy, neuropathy, cardiopathy,etc.
* Some danger of hypoglycemic reaction in Type I diabetics.
* Some glucose intolerant individuals and "subclinical" diabetics may demonstrate HbA1c levels in this area.
EXPLANATION :-
*Total haemoglobin A1 c is continuously synthesised in the red blood cell throught its 120 days life span.The
concentration of HBA1c in the cell reflects the average blood glucose concentration it encounters.
*The level of HBA1c increases proportionately in patients with uncontrolled diabetes. It reflects the average blood
glucose concentration over an extended time period and remains unaffected by short-term fluctuations in blood
glucose levels.
*The measurement of HbA1c can serve as a convenient test for evaluating the adequacy of diabetic control and in
preventing various diabetic complications. Because the average half life of a red blood cell is sixty days,HbA1c has
been accepted as a measurnment which eflects the mean daily blood glucose concentration, better than fasting blood
glucose determination, and the degree of carbohydrate imbalance over the preceding two months.
*It may also provide a better index of control of the diabetic patient without resorting to glucose loading procedures.
HbA1c assay Interferences:
*Errneous values might be obtained from samples with abnormally elevated quantities of other Haemoglobins as a
result of either their simultaneous elution with HbA1c(HbF) or differences in their glycation from that of HbA(HbS)

MD(Path) Approved by : DRTRILOKANI
G-4265
Page 5 of 6
TEST REPORT
HAEMOGRAM (CBC) ( by fully automated 6 part cell counter with autoloader analyser ( mindray BC-6200 )
Test Name Result Unit Biological Reference Interval
Hemoglobin (SLS method) 13.2 gm/dL 13.0 - 18.0

RBC Count (Electrical 4.6 million/cmm 4.5 - 6.5
Impedance)
Hematrocrit (Electrical L 38.6 % 39 - 51
Impedance)
MCV (Calculated) 83.6 /cumm 82 - 101
MCH (Calculated) 28.6 Pg 27 - 32
MCHC (Calculated) 34.2 g/dL 32 - 36
RDW (Calculated) 42.9 % 41 - 54
WBC Count (Flowcytometry) 7300 /cumm 4000 - 11000

DIFFERENTIAL WBC COUNT (Manual By Microscopy)
Neutrophils (%) 62 % 40 - 75
Lymphocytes (%) 23 % 20 - 40
Eosinophils (%) H 09 % 01 - 06
Monocytes (%) 06 % 02 - 10
Basophils (%) 00 % 00 - 01
Platelet Count 2,01,000 /cumm 150000 - 450000
Neutrophils (Abs) 4526 /cmm 2000 - 7000
Lymphocytes (Abs) 1679 /cmm 1000 - 3000
Monocytes (Abs) 438 /cmm 200 - 1000
Eosinophils (Abs) H 657 /cmm 20 - 500
Basophils (Abs) 0 /cmm 00 - 100
Sample Type : EDTA Whole Blood
------------------ End Of Report ------------------

Dr. Namdev Tilokani Validated by : AUTO
G-4265
Page 6 of 6

Test Report

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Test Report

Uploaded by

Copyright:

Available Formats

TEST REPORT

Name : Mr. Ashok Bhosle Reg. No : 403200070

Parameter Result Unit Biological Ref. Interval

Fasting Blood Sugar (FBS) 70.09 mg/dL Normal <= 99

Criteria for the diagnosis of diabetes

1. HbA1c >/= 6.5 *

Report status : Final

MD(Path) Approved by : DRTILOKANI

Parameter Result Unit Biological Ref. Interval

Post Prandial Blood Sugar (PPBS) 163.14 mg/dL Normal <=139

Report status : Final

MD(Path) Approved by : DRTILOKANI

Parameter Result Unit Biological Ref. Interval

Creatinine 1.17 mg/dL 0.4 - 1.4

The equation is only valid in person 18 yrs of age or older

Report status : Final

MD(Path) Approved by : DRTILOKANI

Parameter Result Unit Biological Ref. Interval

HbA1c (by automated analyser NANO H5)

Hb A1C 7.6 mg/dL <6 : Non-diabetic level /

Mean Blood Glucose 171.42 mg/dL

COMMENT Fair glycemic control mg/dL

Report status : Final

MD(Path) Approved by : DRTRILOKANI

Report status : Final

MD(Path) Approved by : DRTRILOKANI

Hemoglobin (SLS method) 13.2 gm/dL 13.0 - 18.0

WBC Count (Flowcytometry) 7300 /cumm 4000 - 11000

------------------ End Of Report ------------------

Report status : Final

MD(Path) Approved by : DRTILOKANI

You might also like